A carregar...
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
OBJECTIVE: To investigate relapse rates after the successful treatment of patients with non‐atypical endometrial hyperplasia who were randomised to either a levonorgestrel‐impregnated intrauterine system (LNG‐IUS; Mirena(®)) or two regimens of oral medroxyprogesterone acetate (MPA) after primary his...
Na minha lista:
| Publicado no: | BJOG |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215722/ https://ncbi.nlm.nih.gov/pubmed/26630538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1471-0528.13763 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|